Share-based Payment Arrangement, Expense of Kuvatris Therapeutics, Inc. from 30 Sep 2021 to 30 Jun 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Kuvatris Therapeutics, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Sep 2021 to 30 Jun 2024.
  • Kuvatris Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Jun 2024 was $151.
  • Kuvatris Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $500,000, a 62% decline from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Kuvatris Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2024 $151* -$1,264,499 01 Apr 2024 30 Jun 2024 10-Q 20 Sep 2024 2024 Q2
Q1 2024 $1,513,399 -$657,223 -30% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2024 2024 Q1
Q3 2023 $3,623,013 $1,064,906 +$17,753 +1.7% 01 Jul 2023 30 Sep 2023 10-Q 14 Jan 2026 2024 Q3
Q2 2023 $3,605,260 $1,264,650 +$1,115,832 +750% 01 Apr 2023 30 Jun 2023 10-Q 20 Sep 2024 2024 Q2
Q1 2023 $2,489,428 $2,170,622 +$1,989,428 +1098% 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024 2024 Q1
Q4 2022 $500,000 $877,165 01 Oct 2022 31 Dec 2022 10-K 30 Mar 2023 2022 FY
Q3 2022 $1,047,153 +$775,029 +285% 01 Jul 2022 30 Sep 2022 10-Q 16 Nov 2023 2023 Q3
Q2 2022 $148,818 01 Apr 2022 30 Jun 2022 10-Q 09 Aug 2023 2023 Q2
Q1 2022 $181,194 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q3 2021 $272,124 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3

Kuvatris Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2022 $500,000 -$800,000 -62% 01 Jan 2022 31 Dec 2022 10-K 30 Mar 2023 2022 FY
2021 $1,300,000 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.